Sonora Investment Management’s Genmab GMAB Stock Holding History

Sonora Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4K	Buy	+91	New	+$4.08K	﹤0.01%	899

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sonora Investment Management's GMAB Position: Q3 2021 in Review

Sonora Investment Management opened a new position in Genmab (GMAB) in Q3 2021: 91 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #899 among its holdings.

211 funds tracked by Wall St. Rank hold GMAB as of Q3 2021.

Sonora Investment Management held 91 shares of Genmab worth $4K as of Q3 2021.
Genmab was a new Sonora Investment Management position in Q3 2021.
Genmab made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #899 holding.
211 funds tracked by Wall St. Rank held Genmab as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.